Shree Pacetronix (BOM:527005) ROCE %: 31.83% (As of Mar. 2026)

What is Shree Pacetronix ROCE %?

Shree Pacetronix BOM:527005 +4.35% 81 ROCE % is 31.83% as of Mar. 2026. GuruFocus rates BOM:527005 with a GF Score™ of 81/100 and a GF Value™ of ₹163.24 (Modestly Undervalued).

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shree Pacetronix's annualized ROCE % for the quarter that ended in Mar. 2026 was 31.83%.

Shree Pacetronix (BOM:527005) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shree Pacetronix ROCE % Related Terms

Shree Pacetronix ROCE % Historical Data

* Premium members only.

The historical data trend for Shree Pacetronix's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Pacetronix ROCE % Chart

Shree Pacetronix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

19.98

56.91

42.12

11.69

28.31

Shree Pacetronix Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															22.39	28.44	46.15	7.22	31.83

81GF Score

Shree Pacetronix Ltd BOM:527005

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shree Pacetronix ROCE % Calculation

Shree Pacetronix's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	46.206	/	( ( (230.453 - 88.66)	+	(257.074 - 72.399) )	/ 2 )
	=	46.206	/	( (141.793	+	184.675)	/ 2 )
	=	46.206	/	163.234
	=	28.31 %

Shree Pacetronix's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	58.784	/	( ( (0 - 0)	+	(257.074 - 72.399) )	/ 1 )
	=	58.784	/	( ( 0	+	184.675 )	/ 1 )
	=	58.784	/	184.675
	=	31.83 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 31.83% mean?

Shree Pacetronix (BOM:527005) has a ROCE % of 31.83% as of Mar. 2026.

Is Shree Pacetronix's ROCE % too high?

Shree Pacetronix's current ROCE % is 31.83%. The Medical Devices & Instruments industry median ROCE % is 2.20. Shree Pacetronix's value of 31.83% is 1346.8% above this industry median. Overall, Shree Pacetronix has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Shree Pacetronix's ROCE % compare to ISRG and BDX?

Shree Pacetronix's ROCE % of 31.83% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Shree Pacetronix's value of 31.83% is 1346.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shree Pacetronix's current ROCE % of 31.83% is 1346.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Pacetronix's current ROCE % is 31.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shree Pacetronix stock overvalued right now?

Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹163.24, compared to a current price of ₹130.70 — trading 19.9% below its estimated fair value. The current ROCE % is 31.83% and 1346.8% above the Medical Devices & Instruments industry median of 2.20. Shree Pacetronix's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current ROCE % is 31.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Pacetronix (BOM:527005) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued. The current stock price of ₹130.70 is trading 19.9% below its estimated GF Value™ of ₹163.24. GuruFocus considers Shree Pacetronix to be Modestly Undervalued.

Key valuation signals for BOM:527005:

ROCE %: 31.83%
GF Value™: ₹163.24 vs. price of ₹130.70 (19.9% below fair value)
GF Score™: 81/100
Industry Position: 1346.8% above the Medical Devices & Instruments median

No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shree Pacetronix Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies BOM:544169 BOM:540468 BOM:533212 NSE:GML NSE:ONYX BOM:531380 BOM:543309 NSE:BMLL NSE:QMSMEDI ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543 XPAR:DIM

Address Plot Number 15, Sector II, Industrial Area, District Dhar, Pithampur, MP, IND, 454775

Website https://www.pacetronix.com

Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.

81GF Score

Get the complete analysis for BOM:527005

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹130.70

Price

₹163.24

GF Value

View BOM:527005 Analysis

See ROCE % data for all stocks →